RIGL - Rigel settles patent litigation regarding its immune thrombocytopenia treatment
2025-03-27 09:59:35 ET
More on Rigel Pharmaceuticals
- Rigel Looks Interesting, But Let's Wait For A Lower Price
- Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript
- Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents
- Rigel Pharmaceuticals appoints Mark W. Frohlich to board of directors
- Rigel Pharmaceuticals sets 2025 sales outlook above estimates